Concentra Group Holdings Parent, Inc. (CON): M&A transaction — Concentra Q4 revenue +5.5% to $465M, adjusted EBITDA +13.6%; closes $265M Nova acquisition; declares $0.0625 dividend

Concentra Group Holdings Parent, Inc.

Q4 revenue $465.0M (+5.5% YoY); net income $22.8M ($0.17 EPS).
FY2024 revenue $1,900.2M (+3.4% YoY); adjusted EBITDA $376.9M (+4.3% YoY).
Closed acquisition of Nova Medical Centers for $265M; adds 67 centers across 5 states.
2025 guidance: revenue ~$2.1B, adjusted EBITDA $410-425M; targeting net leverage ~3.0x in 18-24 months.
Declared quarterly dividend $0.0625/share, payable April 1 to March 18 record date.

item 1.01 item 2.01 item 2.02 item 2.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Concentra Group Holdings Parent, Inc. completed an acquisition involving U.S. Occmed Holdings, LLC d/b/a Nova Medical Centers for $265 million (closed 2025-03-01).

Action: acquisition
Counterparty: U.S. Occmed Holdings, LLC d/b/a Nova Medical Centers
Consideration: $265 million
Closing: 2025-03-01

Exact text from the filing

Pursuant to the terms of the Purchase Agreement, CHS acquired all of the outstanding membership interests of Nova Medical Centers from the Sellers and paid a purchase price of $265 million, subject to certain customary adjustments in accordance with the terms set forth in the Purchase Agreement. CHS financed the transaction using a combination of cash on hand,

View on SEC.gov

Browse all m&a transactions →

Concentra Group Holdings Parent, Inc. filing history →

Source: SEC EDGAR

accession 0002014596-25-000009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.